|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
Acquired_by_Sun_Pharmaceutical_Industries
|
|
gptkbp:awards
|
Various industry awards
|
|
gptkbp:CEO
|
gptkb:Uday_Baldota
|
|
gptkbp:clinicalTrials
|
Conducts clinical trials
|
|
gptkbp:communityEngagement
|
Yes
|
|
gptkbp:drugInterdiction
|
Prescription drugs
Over-the-counter drugs
|
|
gptkbp:employees
|
Approximately 1,500
|
|
gptkbp:founded
|
1950
|
|
gptkbp:founder
|
gptkb:Barrie_Levitt
|
|
gptkbp:globalPresence
|
Yes
|
|
gptkbp:headCoach
|
gptkb:Dr._David_K._Lee
|
|
gptkbp:headquarters
|
gptkb:Hawthorne,_New_York
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Taro Pharmaceutical Industries
|
|
gptkbp:market
|
gptkb:North_America
|
|
gptkbp:partnerships
|
Academic institutions
Research organizations
Various healthcare organizations
Healthcare_providers
|
|
gptkbp:philanthropy
|
Supports education initiatives
Supports community development
Supports health-related charities
|
|
gptkbp:productionCompany
|
Multiple locations
|
|
gptkbp:productLine
|
Topical medications
Injectable medications
Oral medications
|
|
gptkbp:products
|
Generic_pharmaceuticals
|
|
gptkbp:regulatoryCompliance
|
FDA_approved
|
|
gptkbp:research_areas
|
Cardiology
Oncology
Neurology
Infectious diseases
Endocrinology
|
|
gptkbp:researchAndDevelopment
|
Yes
|
|
gptkbp:revenue
|
$1.1 billion (2020)
|
|
gptkbp:specialization
|
Dermatology
|
|
gptkbp:subsidiary
|
Taro Pharmaceuticals USA, Inc.
|
|
gptkbp:sustainabilityInitiatives
|
Yes
|
|
gptkbp:tradedOn
|
gptkb:New_York_Stock_Exchange
|
|
gptkbp:website
|
www.taro.com
|